Dr. Shylendra B. Sreenivasappa
Claim this profileOSF Saint Anthony Medical Center
Studies Cancer
Studies Lung Cancer
14 reported clinical trials
26 drugs studied
Area of expertise
1Cancer
HER2 positive
Stage II
ER positive
2Lung Cancer
Stage II
Stage I
Stage III
Affiliated Hospitals
Clinical Trials Shylendra B. Sreenivasappa is currently running
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about Shylendra B. Sreenivasappa
Clinical Trial Related4 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 11 Active Clinical TrialsTreatments Shylendra B. Sreenivasappa has experience with
- Biospecimen Collection
- Pembrolizumab
- Pemetrexed Disodium
- Gemcitabine Hydrochloride
- Questionnaire Administration
- Surgery
Breakdown of trials Shylendra B. Sreenivasappa has run
Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Shylendra B. Sreenivasappa specialize in?
Shylendra B. Sreenivasappa focuses on Cancer and Lung Cancer. In particular, much of their work with Cancer has involved HER2 positive patients, or patients who are Stage II.
Is Shylendra B. Sreenivasappa currently recruiting for clinical trials?
Yes, Shylendra B. Sreenivasappa is currently recruiting for 9 clinical trials in Rockford Illinois. If you're interested in participating, you should apply.
Are there any treatments that Shylendra B. Sreenivasappa has studied deeply?
Yes, Shylendra B. Sreenivasappa has studied treatments such as Biospecimen Collection, Pembrolizumab, Pemetrexed Disodium.
What is the best way to schedule an appointment with Shylendra B. Sreenivasappa?
Apply for one of the trials that Shylendra B. Sreenivasappa is conducting.
What is the office address of Shylendra B. Sreenivasappa?
The office of Shylendra B. Sreenivasappa is located at: OSF Saint Anthony Medical Center, Rockford, Illinois 61108 United States. This is the address for their practice at the OSF Saint Anthony Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.